<del class="diff-old">
This
page
is
part
of
the
FHIR
Specification
(v0.0.82:
DSTU
1).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
Contraindication-example
This
is
the
narrative
for
the
resource.
See
also
the
XML
or
JSON
format.
Severity:
High
-
Risk
of
internal
bleeding
Those
who
take
acetaminophen
along
with
the
widely
used
blood-thinning
drug
warfarin
may
face
the
risk
of
serious
internal
bleeding.
People
on
warfarin
who
take
acetaminophen
for
at
least
seven
days
in
a
row
should
be
closely
watched
for
bleeding.
500
mg
Acetaminophen
tablet
1/day,
PRN
since
2010
Warfarin
1
MG
TAB
prescribed
Jan.
5,
2014
Mitigation:
Jan
5,
2014
by
Dr.
Adam
Careful:
Asked
patient
to
discontinue
regular
use
of
Tylenol
and
to
consult
with
clinician
if
they
need
to
resume
to
allow
appropriate
INR
monitoring
&nbsp;
Usage
note:
every
effort
has
been
made
to
ensure
that
the
examples
are
correct
and
useful,
but
they
are
not
a
normative
part
of
the
specification.
©
HL7.org
2011+.
FHIR
DSTU
(v0.4.0-4902)
generated
on
Fri,
Mar
27,
2015
00:19+1100.
Links:
What's
a
DSTU?
|
Version
History
|
Specification
Map
|
Compare
to
DSTU1
|
|
Propose
a
change
</del>